Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing North Biotech is a prominent Chinese medical technology company specializing in the development, manufacturing, and distribution of in vitro diagnostic (IVD) products. Established in 1985 and reorganized in 2003, the company has become a leader in the field of chemiluminescence immunoassay (CLIA) and radioimmunoassay (RIA) technologies. Their extensive product portfolio includes diagnostic kits for oncology, thyroid function, infectious diseases, and cardiac markers, as well as automated laboratory instruments. Beijing North Biotech serves a wide range of clinical laboratories and hospitals across China and international markets, focusing on providing high-sensitivity and high-throughput diagnostic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North Biotech.